KCM21

General Information


DRACP ID  DRACP03509

Peptide Name   KCM21

Sequence  KWWWRW

Sequence Length  6

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03509

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C56H66N14O7

Absent amino acids  ACDEFGHILMNPQSTVY

Common amino acids  W

Mass  113659

Pl  11.65

Basic residues  2

Acidic residues  0

Hydrophobic residues  4

Net charge  2

Boman Index  -1115

Hydrophobicity  -200

Aliphatic Index  0

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  22000

Absorbance 280nm  4400

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25289010

Title  Antimicrobial Effects of a Hexapetide KCM21 against Pseudomonas syringae pv tomato DC3000 and Clavibacter michiganensis subsp michiganensis

Doi Not available

Year  2014

Literature 2

Pubmed ID 19734717

Title  Identification of novel bioactive hexapeptides against phytopathogenic bacteria through rapid screening of a Synthetic peptide combinatorial library

Doi Not available

Year  2009

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  5989

DRACP is developed by Dr.Zheng's team.